Immunohistochemical profiles of the most common canine testicular tumours, including the Leydig cell tumours, seminomas, and Sertoli cell tumours were analysed, and the results were compared with those obtained in the corresponding types of human testicular neoplasms. The expressions of vimentin, von Willebrand factor (FVIII), chromogranin A, synaptophysin, and MCM3 were quantified. In the case of Sertoli cell tumours, only canine ones were analysed, since this type of tumour is very rarely diagnosed in men. The expression of the analysed proteins in the testicular tumours was similar. The von Willebrand factor exhibited the strongest expression in Leydig cell tumours in dogs and men, while vimentin was expressed more strongly in dogs (96.7% had an intensity at +++) than in men (62.5% had +++) in the Leydigioma. The immunoexpression of MCM3 in seminomas was high in both men and dogs -90% +++ and 100% +++ respectively. The lack of chromogranin A and synaptophysin was observed in almost 100% of seminomas in men and dogs. This differed from the results obtained for Leydigioma, where chromogranin A was expressed in 70% of dogs at +++ and in 100% of men at ++++. The results may indicate that the antibodies were selected correctly. Their analysis and interpretation provides valuable information concerning the nature of the studied tumours.
Introduction
Due to an increasing incidence of canine testicular neoplasms, their variable histological structure and a frequent occurrence of mixed forms, there is a need to study their immunohistochemical (IHC) characteristics. IHC analyses, routine histological techniques, and expression of selected biological markers may serve as prognostic or predictive factors. The expressions of vimentin, von Willebrand factor, chromogranin A, synaptophysin, and a cell proliferation marker: MiniChromosome Maintenance 3 (MCM3), were analysed. The aim of the study was to determine the detailed IHC profiles of testicular tumours. Moreover, we aimed at finding data that could aid in establishing a prognosis and treatment of patients with these tumours. The expression of vimentin points to non-epithelial origin of the tumour. The expression of the von Willebrand factor, a marker of vascular epithelium, may indirectly reflect the intensity of neo-angiogenesis. If it is analysed together with the expression of MCM3, an established and reliable marker of cell proliferation, it may be helpful in determining aggressiveness of the tumour. Moreover, the presence of chromogranin A and synaptophysin along with the levels of their expression reflect the secretory activity of the tumour. This study is unique in that it presents a comparative IHC analysis of testicular tumour specimens collected from dogs and men living in Lower Silesia, Poland. A similar histological structure of human and canine tumours combined with the fact that both men and dogs with testicular neoplasms shared a similar environment may be helpful in analysing carcinogenesis in these two species.
Material and Methods
The study included 90 specimens of canine testicular tumours (Seminomas, Leydig cell tumours, and Sertoli cell tumours, 30 of each) and 28 human testicular neoplasms (20 Seminomas and 8 Leydig cell tumours). No human Sertoli cell tumours were analysed, as this type of malignancy is very rarely diagnosed in men (12) .
The canine testicular tumours were obtained during surgery or postmortem examination from dogs of various breeds and ages (between 7 and 14 years of age). The human tumour specimens originated from an archival collection of the Hist-Med N.Z., M. Kosiński P. Prajs Histopathology Unit. All diagnoses were verified histopathologically according to the WHO guidelines (8) .
The canine testicular tumour specimens were fixed in 7% buffered formalin for 24 h, embedded in paraffin, and cut into 4 µm-thick sections. The histopathological evaluation of the haematoxylin and eosin stained slides was based on the WHO classification of testicular tumours (8) .
The IHC analyses were conducted on 4 µm-thick paraffin sections mounted on glass slides (Dako, Denmark), deparaffinised in xylene, and dehydrated in alcohol gradients. Antigens in formalin-fixed tissues were discovered by using the EnVision™ FLEX Target Retrieval Solution high pH (Dako, Denmark) retrieval solutions for vimentin, von Willebrand factor, chromogranin A, and synaptophysin. For MCM3 antigen, the EnVision™ FLEX Target Retrieval Solution, low pH (Dako, Denmark) was used. All preparations were heated in a water bath at 96ºC for 20 min. Activity of the endogenous peroxidase was blocked by exposing to the EnVision™ FLEX Peroxidase-Blocking Reagent for 10 min. The following primary DAKO ® antibodies were then added respectively: monoclonal mouse anti-vimentin, clone V9 (1/100 dilution), polyclonal rabbit anti-human von Willebrand factor (1/100 dilution), monoclonal mouse anti-human chromogranin A, clone DAK-A3 (1/100 dilution), monoclonal mouse anti-human synaptophysin, clone DAK-SYNAP (1/100 dilution), Novocastra rabbit monoclonal anti-human antibody MCM3, as well as the clone EP202 (1/50 dilution). The slides were then incubated at room temperature for 20 min. Subsequently, the slides were washed in the EnVision™ FLEX Wash Buffer. Then, the EnVision™ FLEX/HR SM802 visualisation system reagents were applied, and the slides were incubated at room temperature for 20 min. The IHC reactions were developed using 3,3-diaminobenzidine tetrahydrochloride (DAB) and EnVision™ FLEX DAB+ Chromogen (DAKO, Denmark). Finally, the slides were rinsed in distilled water, counterstained with haematoxylin, dehydrated in alcohol gradients, passed through xylene, and sealed.
The slides were subjected to computer-aided image analysis with a computer connected to an Olympus BX53 optic microscope (Olympus, Japan) equipped with an Olympus Color View IIIa digital camera (Olympus, Japan). All measurements were taken using cellA software (Olympus Soft Imaging Solution, Germany).
The expressions of vimentin, chromogranin A, and synaptophysin were scored according to the modified semi-quantitative IRS scale proposed by Remmele (15) . This method takes into account both the proportion of the positively stained cells and the intensity of the colour reaction. The score constitutes the product of both parameters and ranges from 0 to 12 points: no reaction -0 points (-); weak reaction -1-2 points (+); moderate reaction -3-5 points (++); intense reaction -6-12 points (+++). The expression of MCM3 was evaluated quantitatively, based on the percentage of positively-stained cells: 0-5% -no reaction (-); 6-25% -weak reaction (+); 26-50% -moderate reaction (++); above 50% -intense reaction (+++). The von Willebrand expression was assessed based on the average number of blood vessels seen in five fields of view at a 400× magnification. The expression of the investigated markers was assessed independently by three professionals experienced in evaluating microscopic immunohistochemical reactions; thereby the average result obtained by each of the investigators was taken into account. The results were subjected to statistical analysis using Statistica for Windows, version 10.0 (StatSoft, Poland). The data were analysed with a non-parametric Mann-Whitney U-test, Wilcoxon signed-rank test, and the Spearman's rank correlation test. The threshold of statistical significance for all the tests was set at P ≤ 0.05.
Results
The results obtained are presented in Tables 1-4 and Figs 1-3 .
The statistical analysis revealed that canine and human seminomas did not differ significantly in terms of their MCM3, von Willebrand factor, and synaptophysin expression levels (P = 0.29, P = 0.13, and P = 0.89 respectively, Table 2 and Table 4) . Similarly, no significant differences were documented in the MCM3, von Willebrand factor, and chromogranin expression levels in canine and human Leydig cell tumours (P = 0.69, P = 0.98, and P = 0.36 respectively Table 1 and Table 4 ). A significant positive correlation between the expressions of vimentin and synaptophysin (r = 0.43; P < 0.05) in human and canine Leydig cell tumours was found when the expressions of these proteins were analysed together. However, when the Leydig cell tumours from the two species were analysed separately, the positive correlation between vimentin and synaptophysin expressions (r = 0.44; P < 0.05) was documented solely in the case of canine neoplasms, and an inverse correlation was found between the two parameters (r = -0.8; P < 0.05) in the case of human tumours. We did not find any significant correlations between the expressions of the analysed proteins in the canine Sertoli cell tumours. The levels of the chromogranin A expression in the canine Sertoli and Leydig cell tumours turned out to be significantly lower than the expression of synaptophysin (P = 0.001 and P = 0.025, respectively). In contrast, we did not find significant differences in the chromogranin A and synaptophysin expression levels in human Leydig cell tumours, whether analysed separately or pooled with canine neoplasms of the same type (P = 0.07 and P = 0.12 respectively). The fact that the Leydig cell tumours showed a strong expression of the von Willebrand factor, a marker of vascular endothelial cells (5, 14, 20) , suggests that these neoplasms may show an enhanced angiogenesis. This seems to be consistent with frequent macroscopic evidence of haemorrhagic foci in these tumours, and point to the presence of structural abnormalities in the tumour vessels (6) . The expression of the von Willebrand factor in the remaining neoplasms was weaker than in the Leydig cell tumours. Better vascularisation resulting in more efficient supply of nutrients and oxygen to cancer cells enables faster growth of the tumour and formation of metastases. If analysed together with the expression of MCM3, which is a marker of cell proliferation, the expression of the von Willebrand factor may provide additional information on the rate of the tumour growth, and thus on the aggressiveness of the lesion. To the best of our knowledge, none of the previous studies analysed the expression of MCM3 in canine and human testicular tumours. This protein is involved in the cell cycle progression, and is a component of the pre-replication complex (pre-RC). The Mini-Chromosome Maintenance (MCM) complex is composed of a number of MCM proteins (from MCM2 to MCM7) and is a crucial element of the pre-RC (11, 18) . Therefore, it seems to be an accurate marker of cell proliferation.
The presence and intensity of the expression of synaptophysin and chromogranin A, which are markers of neuroendocrine cells, may reflect secretory activity of testicular tumours (16, 19) . Synaptophysin belongs to the family of proteins with four transmembrane domains. Synaptogirin and synaptoporin are the other members of this family. Synaptophysin is a component of synaptic vesicle membranes. It is involved in the exocytosis of neuromediators to the synaptic space and the formation of synapses. Under physiological conditions, this protein is secreted by endocrine cells and natural killer cells (10) . We observed a strong expression of synaptophysin in the testicular tumours with potential secretory activity, i.e. in Leydig and Sertoli cell tumours. This marker was only sporadically found in seminomas. The fact that similar results were obtained for human and canine neoplasms suggests that the Leydig and Sertoli tumour cells may retain their hormonal activity. Our findings are consistent with the data published by Saegusa et al. (17) , and Kuroda et al. (9) . Chromogranin A is a prohormone, which can be converted to several active forms, i.e.: chromostatin, pancreastatin, parastatin, and vasostatin. These peptides inhibit the secretion of other hormones. The expression of chromogranin A is proportional to the secretory activity of the tumour (4). We found a strong expression of chromogranin A in potentially hormonally-active neoplasms, i.e. Leydig and Sertoli cell tumours. The cells of these two tumour types showed a strong expression of this protein. Importantly, the expression of chromogranin A was found in both human and canine Leydig cell tumours. The expression of chromogranin A in these neoplasms was previously reported by Kuroda et al. (9) and Davidoff et al. (3) . The lack of chromogranin A in canine and human seminomas seems to further prove the character of these tumours, namely their complete lack or limited hormonal activity.
The statistical analysis revealed that irrespective of histological type, canine and human testicular tumours are characterised by similar patterns and intensity of MCM3 and von Willebrand factor expression. Moreover, the Leydig cell tumours from men and dogs showed similar levels of chromogranin A expression and seminomas -a similar level of synaptophysin. Vimentin was the only marker whose expression differed significantly between canine and human testicular neoplasms. The fact that we detected all analysed proteins in both canine and human testicular tumours may reflect an appropriate selection of specific antibodies. Therefore, provided the interpretation is correct, the hereby reported immunohistochemical parameters may provide valuable information on the character of canine and human testicular tumours. The panel of antibodies tested in our study may be useful for their routine accurate evaluation. The results may also be used to broaden the spectrum of cell markers used in the studies on testicular tumours (2) . The fact that the analysed canine and human tumours originated from the same region of Poland and did not differ in terms of the expression patterns in most of the studied molecular markers may justify the use of a canine model in research concerning the carcinogenesis in human testes.
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